Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
HER2 peptide (369-377)
×
Breast
×
Clear all
Filters
3
NCT02297698
2023-12-12
HER3+
Cancer Insight, LLC
Phase 2
Completed
100 enrolled
11 charts
NCT01479244
2017-02-27
PRESENT
Galena Biopharma, Inc.
Phase 3
Completed
758 enrolled